Molecular basis for universal HLA-A(star)0201-restricted CD8( ) T-cell immunity against influenza viruses
Sophie A Valkenburg, Tracy M Josephs, E Bridie Clemens, Emma J Grant, Thi HO Nguyen, George C Wang, David A Price, Adrian Miller, Steven YC Tong, Paul G Thomas, Peter C Doherty, Jamie Rossjohn, Stephanie Gras, Katherine Kedzierska
Proceedings of the National Academy of Sciences | NATL ACAD SCIENCES | Published : 2016
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by NHMRC
Awarded by Wellcome Trust
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
We thank Nicola Bird for technical assistance and Natalie Saunders for sorting. The C1R-B<SUP>star</SUP>3501 plasmid was provided by Dr. David Cole (Cardiff University). HLA-A2.1 transgenic HHD mice were developed and provided by Dr. Francois Lemonnier (Pasteur Institute). This work was supported by National Health and Medical Research Council (NHMRC) Project Grant 1042662 (to A.M., S.Y.C.T., and K.K.) and NHMRC Program Grant 567122 (to P.C.D. and K.K.). S.A.V. is an NHMRC Early Career Research Fellow, E.B.C. is an NHMRC Peter Doherty Fellow, D.A.P. is a Wellcome Trust Senior Investigator, S.Y.C.T. and K.K. are NHMRC Career Development Fellows, J.R. is an NHMRC Australia Fellow (AF50), and S.G. is an Australian Research Council Future Fellow (FT120100416). E.J.G. is a recipient of an NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship.